ArticleJournal of neuro-oncology2019

Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.

Junmei Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.